![]() The company was incorporated in 2011 and is headquartered in Bedminster, New Jersey. ![]() The company was formerly known as Global Group Enterprises Corp. It has research collaborations with Mayo Clinic to perform in-depth analysis of pancreatic cancer cell gene expression, epigenetic, and metabolism changes from SM-88 treatment and a research investigator at Georgetown University to examine the effects of SM-88 in breast cancer. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the treatment of SARS CoV-2 diseases and TYME-18, a CMBT compound that is in preclinical stage for the treatment of inoperable tumors. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The business earned 8.61 billion during the quarter, compared to analysts expectations of 8.51 billion. Tyme Technologies Stock Smart Score Tyme Technologies News Company Description Forecast EPS vs Actual EPS Financials Product Monthly Users Risk Analysis. The ride-sharing company reported 0.29 earnings per share (EPS) for the quarter, topping analysts consensus estimates of (0.21) by 0.50. Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Uber Technologies last issued its quarterly earnings results on February 8th, 2023. 3 Reasons Why Apple’s 30% Rally Has Legs.Hypercharge Networks: Up Triple Digits, But What’s The Big Deal?.2 Beautiful Investments In A Growing Industry.What Factors Will Drive S&P 500 Performance This Year?.Walmart Makes Moves for Efficiency with Robots to Spur Sales.FedEx Takes Flight Analysts See More Gains Ahead.3 Low-Cost Stock ETFs That Are Crushing It This Year.The WD-40 Company Bottoms With Reversal In Sight.First Republic Bank Is A Speculative Play, Here’s Why View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks.Costco Sales Disappoint, Markets Are Missing This Upside Driver.Investing in Cybersecurity Stocks: The AI Advantage.Tesla Stock: Reasons to Worry or Reasons to Buy.Finding High-Yield Value Stocks: Guide For Investors.The Trader's Guide to Equities Research.
0 Comments
Leave a Reply. |